Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon-stimulated genes (ISGs) are genes whose expression is induced by interferons, a family of cytokines central to the innate immune response. ISGs encode a diverse group of proteins with key roles in antiviral defense, including the detection of pathogens, inhibition of viral replication, induction of apoptosis, and regulation of immune signaling pathways. The ISG response can be triggered by type I, II, or III interferons, each of which stimulates a repertory of genes involved in host defense, inflammation, and immune modulation. ISG products are critical for limiting the spread of viruses, bacteria, and parasites, and for shaping subsequent adaptive immune responses. Dysregulation of ISG expression is implicated in several disease processes, including chronic inflammation, neurodegeneration, autoimmunity, and cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon-stimulated gene (ISG).